MyAverix Finance
F · Healthcare
Larimar Therapeutics Inc (ZA71)
Biotechnology
Larimar Therapeutics Inc (ZA71) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-31, reported market cap is $392.49M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ZA71
Larimar Therapeutics Inc (ZA71) — FAQ
What is Larimar Therapeutics Inc's market cap?
Larimar Therapeutics Inc (ZA71) has a reported market cap of $392.49M (data as of 2026-03-31).
What is ZA71's P/E ratio?
The price-to-earnings (P/E) ratio for Larimar Therapeutics Inc (ZA71) is 18.00 (data as of 2026-03-31).
Does Larimar Therapeutics Inc pay a dividend?
Dividend yield is not available in the current snapshot for Larimar Therapeutics Inc (ZA71). Check the MyAverix Finance app for the latest dividend data.
What sector is Larimar Therapeutics Inc in?
Larimar Therapeutics Inc (ZA71) is classified in the Healthcare sector (Biotechnology industry).
What exchange is ZA71 listed on?
ZA71 is listed on F.
What is Larimar Therapeutics Inc's net margin?
Larimar Therapeutics Inc (ZA71) reports a net margin of 0.0% (data as of 2026-03-31).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.